Mant-GTPγS (triammonium)

Mant-GTPγS (triammonium)

• UNSPSC Description: Mant-GTPγS triammonium, a GTP mimetic, is a potent competitive adenylyl cyclase (AC) inhibitor. Mant-GTPγS triammonium is a potent YdeH inhibitor[1][2][3].
• Target Antigen: Adenylate Cyclase
• Type: Reference compound
• Related Pathways: GPCR/G Protein
• Applications: Neuroscience-Neuromodulation
• Field of Research: Cardiovascular Disease
• Assay Protocol: https://www.medchemexpress.com/mant-gtpγs-triammonium.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(C1=CC=CC=C1NC)[穄.O=C2C(N=CN3[C@H]4[C@H](O[R])[C@H](O[R])[C@@H](COP(OP(OP(O)(O)=S)(O)=O)(O)=O)O4)=C3N=C(N)N2.[or].[H].N.N.N
• Molecular Weight: 723.48
• References & Citations: [1]Andreas Gille, et al. 2'(3')-O-(N-methylanthraniloyl)-substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors. J Biol Chem. 2003 Apr 11;278(15):12672-9.|[2]Tomoharu Kanie, et al. The CEP19-RABL2 GTPase Complex Binds IFT-B to Initiate Intraflagellar Transport at the Ciliary Base. Dev Cell. 2017 Jul 10;42(1):22-36.e12.|[3]Christian Spangler, et al. Interaction of the diguanylate cyclase YdeH of Escherichia coli with 2',(3')-substituted purine and pyrimidine nucleotides. J Pharmacol Exp Ther. 2011 Jan;336(1):234-41.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported